IDO1 Rekombinanter Antikörper

IDO1 Rekombinant Antikörper für WB, FC (Intra), ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, FC (Intra), ELISA

Konjugation

Unkonjugiert

CloneNo.

241110C8

Kat-Nr. : 84063-1-RR

Synonyme

INDO, IDO-1, IDO 1, IDO, EC:1.13.11.52

---

• 

  WB analysis of HeLa using 84063-1-RR

  IFN gamma treated HeLa cells were subjected to SDS PAGE followed by western blot with 84063-1-RR (IDO1 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours.

• 

  FC experiment of HeLa using 84063-1-RR

  1x10^6 IFN-gamma treated HeLa cells were intracellularly stained with 0.25 ug Ido1 Recombinant Antibody (84063-1-RR, Clone:241110C8) and APC-Conjugated Goat Anti-Rabbit IgG(H+L)(red), or 0.25 ug Isotype Control (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

• 

  Affinity and Kinetic Characterization of 84063-1-RR

  Biolayer interferometry (BLl) kinetic assays of 84063-1-RR against Human IDO1 were performed. The affinity constant is below 1 pM.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: mit IFN-gamma behandelte HeLa-Zellen
• Erfolgreiche Detektion in FC (Intra): IFN-gamma treated HeLa cells

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:1000-1:8000
• Durchflusszytometrie (FC) (INTRA): FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Produktinformation

84063-1-RR bindet in WB, FC (Intra), ELISA IDO1 und zeigt Reaktivität mit human

• Getestete Reaktivität: human
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Rekombinant
• Typ: Antikörper
• Immunogen: IDO1 fusion protein Ag3953
• Vollständiger Name: indoleamine 2,3-dioxygenase 1
• Berechnetes Molekulargewicht: 403 aa, 45 kDa
• Beobachtetes Molekulargewicht: 45 kDa
• GenBank-Zugangsnummer: BC027882
• Gene symbol: IDO1
• Gene ID (NCBI): 3620
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Protein-A-Reinigung
• Lagerungspuffer: PBS with 0.02% sodium azide and 50% glycerol
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

IDO1 is the target for therapy in a range of clinical settings, including cancer, chronic infections, autoimmune and allergic syndromes, and transplantation. Elevated IDO1 expression is a hallmark of major viral infections including HIV, HBV, HCV or influenza and also of major bacteria infections, such as Tb, CAP, listeriosis and sepsis. Pathogens are able to highjack the immunosuppressive effects of IDO1 and make use of them to facilitate their own life cycle. MW of IDO1 is 40-42kd (PMID: 14502282; 17055065).